Show simple item record

dc.contributor.authorHealth Protection Surveillance Centre
dc.date.accessioned2021-10-13T09:12:41Z
dc.date.available2021-01-26T15:27:09Z
dc.date.available2021-04-13T10:58:46Z
dc.date.available2021-04-19T14:14:08Z
dc.date.available2021-04-23T09:51:58Z
dc.date.available2021-06-11T13:27:55Z
dc.date.available2021-07-07T13:42:53Z
dc.date.available2021-10-01T09:10:08Z
dc.date.available2021-10-13T09:12:41Z
dc.date.issued2021-09-30
dc.identifier.urihttp://hdl.handle.net/10147/628851
dc.descriptionThese FAQs are based on HIQA evidence syntheses, public health and clinical evidence summaries which have informed the HIQA-Expert Advisory Group (EAG) available at https://www.hiqa.ie/areas-we-work/health-technology-assessment/covid-19-publications. They also include advice and decisions of the former COVID-19 EAG (Jan-Sept 2020) and the HSE Antigen Detection Testing (ADT) group.en_US
dc.language.isoenen_US
dc.publisherHealth Service Executiveen_US
dc.subjectCoronavirusen_US
dc.subjectCOVID-19en_US
dc.subjectINFECTION PREVENTION AND CONTROLen_US
dc.subjectPUBLIC HEALTHen_US
dc.titleCOVID-19: Frequently Asked Questions: asymptomatic infection, re-infection, immunity, and GP management of patients with COVID-19 test results from a laboratory other than the public laboratory service. [v2.3]en_US
dc.typeOtheren_US
refterms.dateFOA2021-01-26T15:27:10Z


Files in this item

Thumbnail
Name:
v2.3FAQs_immunity.pdf
Size:
300.1Kb
Format:
PDF
Thumbnail
Name:
v2.2FAQs_immunity.pdf
Size:
303.2Kb
Format:
PDF
Thumbnail
Name:
v2.0FAQs_immunity.pdf
Size:
303.3Kb
Format:
PDF
Thumbnail
Name:
v1.9FAQs_immunity.pdf
Size:
300.6Kb
Format:
PDF
Thumbnail
Name:
v1.8FAQs_immunity.pdf
Size:
288.1Kb
Format:
PDF
Thumbnail
Name:
v1.7FAQs_immunity (2).pdf
Size:
278.2Kb
Format:
PDF
Thumbnail
Name:
v1.6FAQs_immunity.pdf
Size:
282.7Kb
Format:
PDF
Thumbnail
Name:
FAQs_immunity.pdf
Size:
265.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record